Annual Statements Open main menu

ROPER TECHNOLOGIES INC - Quarter Report: 2014 March (Form 10-Q)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549


FORM 10-Q


[X] QUARTERLY  REPORT PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934
For the quarterly period ended March 31, 2014.

[  ] TRANSITION REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934
For the transition period from                 to                .

Commission File Number   1-12273


ROPER INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

Delaware
(State or other jurisdiction of
incorporation or organization)
51-0263969
(I.R.S. Employer Identification No.)
 
6901 Professional Pkwy. East, Suite 200
Sarasota, Florida
(Address of principal executive offices)
 
34240
(Zip Code)
 
(941) 556-2601
(Registrant's telephone number, including area code)
     
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  þ Yes ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  þ Yes ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

þ Large accelerated filer
¨ Accelerated filer
¨ Non-accelerated filer
     (do not check if smaller reporting company)
¨ Smaller reporting company

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Act). ¨ Yes þ No

The number of shares outstanding of the Registrant's common stock as of April 25, 2014 was 99,787,266.


ROPER INDUSTRIES, INC.

REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014

TABLE OF CONTENTS

 
 
   Page
PART I.
FINANCIAL INFORMATION
 
 
Item 1.
Financial Statements (unaudited):
 
 
 
Condensed Consolidated Statements of Earnings
 
3
 
Condensed Consolidated Statements of Comprehensive Income
 
4
 
Condensed Consolidated Balance Sheets
 
5
 
Condensed Consolidated Statements of Cash Flows
 
6
 
Condensed Consolidated Statement of Changes in Stockholders' Equity
 
7
 
Notes to Condensed Consolidated Financial Statements
 
8
Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
 
13
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
 
19
Item 4.
Controls and Procedures
 
19
PART II.
OTHER INFORMATION
 
 
Item 1.
Legal Proceedings
 
20
Item 1A.
Risk Factors
 
20
Item 6.
Exhibits
 
20
 
Signatures
 
21


PART I. FINANCIAL INFORMATION

ITEM 1.                          FINANCIAL STATEMENTS


Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Earnings (unaudited)
(in thousands, except per share data)

 
 
 
Three months ended
March 31,
 
 
 
2014
 
2013
 
 
 
 
 
 
 
 
 
Net sales
 
$
834,052
 
$
737,135
 
Cost of sales    
 
 
345,116
 
 
315,559
 
Gross profit    
 
 
488,936
 
 
421,576
 
 
 
 
 
 
 
 
 
Selling, general and administrative expenses    
 
 
265,536
 
 
236,399
 
Income from operations    
 
 
223,400
 
 
185,177
 
 
 
 
 
 
 
 
 
Interest expense, net    
 
 
19,827
 
 
20,858
 
Other income/(expense), net
 
 
1,420
 
 
(2,492
)
 
 
 
 
 
 
 
 
Earnings before income taxes    
 
 
204,993
 
 
161,827
 
 
 
 
 
 
 
 
 
Income taxes    
 
 
57,767
 
 
36,913
 
 
 
 
 
 
 
 
 
Net earnings    
 
$
147,226
 
$
124,914
 
 
 
 
 
 
 
 
 
Earnings per share:    
 
 
 
 
 
 
 
Basic
 
$
1.48
 
$
1.26
 
Diluted
 
 
1.46
 
 
1.25
 
     
 
 
 
 
 
 
 
Weighted average common shares outstanding:    
 
 
 
 
 
 
 
Basic
 
 
99,557
 
 
98,876
 
Diluted
 
 
100,572
 
 
99,986
 
 
 
 
 
 
 
 
 
Dividends declared per common share
 
$
0.200
 
$
0.165
 
 
 
 
 
 
 
 
 


See accompanying notes to condensed consolidated financial statements.



Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income (unaudited)
(in thousands)

 
 
 
Three months ended
March 31,
 
 
 
2014
 
 
2013
 
 
 
 
 
 
 
 
 
 
Net earnings    
 
$
147,226
 
 
$
124,914
 
 
 
 
 
 
 
 
 
 
Other comprehensive income/(loss), net of tax:
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
 
(12,811
)
 
 
(38,489
)
 
 
 
 
 
 
 
 
 
Total other comprehensive income/(loss), net of tax
 
 
(12,811
)
 
 
(38,489
)
 
 
 
 
 
 
 
 
 
Comprehensive income
 
$
134,415
 
 
$
86,425
 
 
 
 
 
 
 
 
 
 


See accompanying notes to condensed consolidated financial statements.


Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets (unaudited)
(in thousands)
 
 
 
March 31, 2014
 
December 31, 2013
 
ASSETS:    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
502,885
 
$
459,720
 
Accounts receivable, net 
 
 
514,081
 
 
519,075
 
Inventories, net
 
 
209,383
 
 
204,923
 
Deferred taxes    
 
 
70,069
 
 
64,464
 
Unbilled receivables
 
 
95,274
 
 
86,945
 
Other current assets
 
 
40,478
 
 
38,210
 
Total current assets
 
 
1,432,170
 
 
1,373,337
 
 
 
 
 
 
 
 
 
Property, plant and equipment, net
 
 
116,590
 
 
117,310
 
Goodwill
 
 
4,540,022
 
 
4,549,998
 
Other intangible assets, net 
 
 
1,997,924
 
 
2,039,136
 
Deferred taxes
 
 
27,196
 
 
28,773
 
Other assets
 
 
75,801
 
 
76,427
 
 
 
 
 
 
 
 
 
Total assets
 
$
8,189,703
 
$
8,184,981
 
 
 
 
 
 
 
 
 
LIABILITIES AND STOCKHOLDERS' EQUITY:    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable
 
$
144,168
 
$
150,313
 
Accrued compensation
 
 
92,820
 
 
107,953
 
Deferred revenue
 
 
207,957
 
 
209,332
 
Other accrued liabilities
 
 
162,559
 
 
153,712
 
Income taxes payable
 
 
43,035
 
 
4,275
 
Deferred taxes
 
 
6,511
 
 
6,490
 
Current portion of long-term debt, net
 
 
10,923
 
 
11,016
 
Total current liabilities
 
 
667,973
 
 
643,091
 
 
 
 
 
 
 
 
 
Long-term debt, net of current portion
 
 
2,304,143
 
 
2,453,836
 
Deferred taxes
 
 
771,243
 
 
783,805
 
Other liabilities
 
 
89,099
 
 
91,199
 
Total liabilities
 
 
3,832,458
 
 
3,971,931
 
 
 
 
 
 
 
 
 
Commitments and contingencies (Note 9)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Common stock
 
 
1,017
 
 
1,013
 
Additional paid-in capital
 
 
1,258,910
 
 
1,229,233
 
Retained earnings
 
 
3,086,465
 
 
2,959,196
 
Accumulated other comprehensive earnings
 
 
30,272
 
 
43,083
 
Treasury stock
 
 
(19,419
)
 
(19,475
)
Total stockholders' equity
 
 
4,357,245
 
 
4,213,050
 
 
 
 
 
 
 
 
 
Total liabilities and stockholders' equity
 
$
8,189,703
 
$
8,184,981
 


See accompanying notes to condensed consolidated financial statements.


Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows (unaudited)
(in thousands)

 
 
 
Three months ended
March 31,
 
 
 
2014
 
 
2013
 
Cash flows from operating activities:
 
 
 
 
 
 
 
 
Net earnings
 
$
147,226
 
 
$
124,914
 
Adjustments to reconcile net earnings to cash flows from operating activities:
 
 
 
 
 
 
 
 
Depreciation and amortization of property, plant and equipment
 
 
9,666
 
 
 
9,342
 
Amortization of intangible assets
 
 
39,037
 
 
 
34,099
 
Amortization of deferred financing costs
 
 
1,002
 
 
 
837
 
Non-cash stock compensation
 
 
14,571
 
 
 
12,977
 
Changes in operating assets and liabilities, net of acquired businesses:
 
 
 
 
 
 
 
 
Accounts receivable
 
 
4,582
 
 
 
27,590
 
Unbilled receivables
 
 
(8,346
)
 
 
(13,136
)
Inventories
 
 
(4,712
)
 
 
(11,687
)
Accounts payable and accrued liabilities
 
 
(12,887
)
 
 
(25,510
)
Income taxes payable
 
 
24,829
 
 
 
16,348
 
Other, net
 
 
(2,340
)
 
 
(4,506
)
Cash provided by operating activities
 
 
212,628
 
 
 
171,268
 
 
 
 
 
 
 
 
 
 
Cash flows from investing activities:
 
 
 
 
 
 
 
 
Acquisitions of businesses, net of cash acquired
 
 
(2,146
)
 
 
(2,240
)
Capital expenditures
 
 
(10,478
)
 
 
(11,205
)
Proceeds from sale of assets
 
 
341
 
 
 
236
 
Other, net
 
 
(233
)
 
 
(1
)
Cash used in investing activities
 
 
(12,516
)
 
 
(13,210
)
 
 
 
 
 
 
 
 
 
Cash flows from financing activities:
 
 
 
 
 
 
 
 
Payments under revolving line of credit
 
 
(150,000
)
 
 
(100,000
)
Principal payments on convertible notes
 
 
(433
)
 
 
(52
)
Cash premiums paid on convertible note conversions
 
 
(1,174
)
 
 
(109
)
Cash dividends to stockholders
 
 
(19,863
)
 
 
-
 
Proceeds from stock based compensation, net
 
 
8,026
 
 
 
6,229
 
Stock award tax excess windfall benefit
 
 
7,511
 
 
 
4,364
 
Treasury stock sales
 
 
729
 
 
 
642
 
Other
 
 
573
 
 
 
122
 
Cash used in financing activities
 
 
(154,631
)
 
 
(88,804
)
 
 
 
 
 
 
 
 
 
Effect of foreign currency exchange rate changes on cash
 
 
(2,316
)
 
 
(9,822
)
 
 
 
 
 
 
 
 
 
Net increase in cash and cash equivalents
 
 
43,165
 
 
 
59,432
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, beginning of period
 
 
459,720
 
 
 
370,590
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents, end of period
 
$
502,885
 
 
$
430,022
 



See accompanying notes to condensed consolidated financial statements.


Roper Industries, Inc. and Subsidiaries
Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited)
(in thousands)



 
 
 
Common
stock
 
Additional paid-in capital
 
Retained
earnings
 
Accumulated other comprehensive earnings
 
Treasury
stock
 
Total
 
Balances at December 31, 2013
 
$
1,013
 
$
1,229,233
 
$
2,959,196
 
$
43,083
 
$
(19,475
)
$
4,213,050
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net earnings    
 
 
-
 
 
-
 
 
147,226
 
 
-
 
 
-
 
 
147,226
 
Stock option exercises    
 
 
2
 
 
9,951
 
 
-
 
 
-
 
 
-
 
 
9,953
 
Treasury stock sold
 
 
-
 
 
673
 
 
-
 
 
-
 
 
56
 
 
729
 
Currency translation adjustments, net of $1,278 tax
 
 
-
 
 
-
 
 
-
 
 
(12,811
)
 
-
 
 
(12,811
)
Stock based compensation 
 
 
-
 
 
14,569
 
 
-
 
 
-
 
 
-
 
 
14,569
 
Restricted stock activity    
 
 
2
 
 
(1,930
)
 
-
 
 
-
 
 
-
 
 
(1,928
)
Stock option tax benefit, net of shortfalls
 
 
-
 
 
7,485
 
 
-
 
 
-
 
 
-
 
 
7,485
 
Conversion of senior subordinated convertible notes, net of $103 tax
 
 
-
 
 
(1,071
)
 
-
 
 
-
 
 
-
 
 
(1,071
)
Dividends declared
 
 
-
 
 
-
 
 
(19,957
)
 
-
 
 
-
 
 
(19,957
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances at March 31, 2014
 
$
1,017
 
$
1,258,910
 
$
3,086,465
 
$
30,272
 
$
(19,419
)
$
4,357,245
 

See accompanying notes to condensed consolidated financial statements.


Roper Industries, Inc. and Subsidiaries
Notes to Condensed Consolidated Financial Statements (unaudited)
March 31, 2014


1.
Basis of Presentation

The accompanying condensed consolidated financial statements for the three month periods ended March 31, 2014 and 2013 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Industries, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2013 financial position data included herein was derived from the audited consolidated financial statements included in the 2013 Annual Report on Form 10-K ("Annual Report") filed on February 21, 2014 with the Security and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three month period ended March 31, 2014 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.


2.
Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.  All recent ASUs were assessed and determined to be either not applicable or are not expected to have a material impact on the Company's results of operations, financial position or cash flows.


3.
Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are shown below (in thousands):
 
 
Three months ended
March 31,
 
 
 
2014
 
2013
 
Basic shares outstanding    
 
99,557
 
98,876
 
Effect of potential common stock    
 
 
 
 
 
Common stock awards
 
864
 
892
 
Senior subordinated convertible notes 
 
151
 
218
 
Diluted shares outstanding    
 
100,572
 
99,986
 

For the three months ended March 31, 2014 there were 1,093,600 outstanding stock options that were not included in the determination of diluted earnings per share because doing so would have been antidilutive, as compared to 568,850 outstanding stock options that would have been antidilutive for the three months ended March 31, 2013.
 
 
4.
Stock Based Compensation

The Roper Industries, Inc. Amended and Restated 2006 Incentive Plan is a stock-based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. Common stock sold to employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock-based compensation expense (in thousands):

 
Three months ended
March 31,
 
2014
2013
Stock based compensation
$  14,571
$  12,977
Tax effect recognized in net income
5,100
4,542
Windfall tax benefit, net
7,485
4,312

Stock Options - In the quarter ended March 31, 2014, 533,000 options were granted with a weighted average fair value of $35.14 per option. During the same period in 2013, 447,850 options were granted with a weighted average fair value of $36.53 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.

 

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during current and prior year quarters using the Black-Scholes option-pricing model:

 
Three months ended March 31,
 
2014
 
2013
Risk-free interest rate (%)
1.62
 
0.80
Expected option life (years)
5.24
 
5.18
Expected volatility (%)
27.62
 
36.29
Expected dividend yield (%)
0.59
 
0.57

Cash received from option exercises for the three months ended March 31, 2014 and 2013 was $10.0 million and $9.6 million, respectively.

Restricted Stock Awards - During the quarter ended March 31, 2014, 237,001 restricted stock awards were granted with a weighted average fair value of $139.62 per restricted share. During the same period in 2013, 261,390 restricted stock awards were granted with a weighted average fair value of $115.36 per restricted share. All grants were issued at grant date fair value.

During the quarter ended March 31, 2014, 32,161 restricted awards vested with a weighted average grant date fair value of $79.06 per restricted share, and a weighted average vest date fair value of $140.42 per restricted share.

Employee Stock Purchase Plan - During the three month periods ended March 31, 2014 and 2013, participants of the employee stock purchase plan purchased 5,664 and 5,594 shares, respectively, of Roper's common stock for total consideration of $0.73 million and $0.64 million, respectively. All shares were purchased from Roper's treasury shares.
 

 
5.
Inventories

The components of inventory were as follows (in thousands):

 
 
March 31,
2014
 
December 31,
2013
 
Raw materials and supplies
 
$
130,481
 
$
127,525
 
Work in process
 
 
32,650
 
 
30,498
 
Finished products
 
 
90,056
 
 
90,352
 
Inventory reserves
 
 
(43,804
)
 
(43,452
)
 
 
$
209,383
 
$
204,923
 


6.
Goodwill and Other Intangible Assets

The carrying value of goodwill by segment was as follows (in thousands):

 
Industrial Technology
 
Energy Systems & Controls
 
Medical & Scientific Imaging
 
RF Technology
 
Total
 
Balances at December 31, 2013
$
425,501
 
$
434,697
 
$
2,435,506
 
$
1,254,294
 
$
4,549,998
 
Other
 
-
 
 
-
 
 
(2,266
)
 
-
 
 
(2,266
)
Currency translation adjustments
 
591
 
 
(294
)
 
(8,062
)
 
55
 
 
(7,710
)
Balances at March 31, 2014
$
426,092
 
$
434,403
 
$
2,425,178
 
$
1,254,349
 
$
4,540,022
 

Other relates to a tax purchase accounting adjustment for MHA, Inc., acquired in May 2013.

Other intangible assets were comprised of (in thousands):

 
 
Cost
 
Accumulated
amortization
 
Net book
value
 
Assets subject to amortization:
 
 
 
 
 
 
 
Customer related intangibles
 
$
1,936,336
 
$
(464,018
)
$
1,472,318
 
Unpatented technology
 
 
216,044
 
 
(120,091
)
 
95,953
 
Software
 
 
160,618
 
 
(58,084
)
 
102,534
 
Patents and other protective rights
 
 
31,394
 
 
(21,922
)
 
9,472
 
Trade names
 
 
656
 
 
(16
)
 
640
 
Assets not subject to amortization:
 
 
 
 
 
 
 
 
 
 
Trade names
 
 
358,219
 
 
-
 
 
358,219
 
Balances at December 31, 2013
 
$
2,703,267
 
$
(664,131
)
$
2,039,136
 
Assets subject to amortization:
 
 
 
 
 
 
 
 
 
 
Customer related intangibles
 
$
1,933,576
 
$
(491,047
)
$
1,442,529
 
Unpatented technology
 
 
209,107
 
 
(120,104
)
 
89,003
 
Software
 
 
152,441
 
 
(53,116
)
 
99,325
 
Patents and other protective rights
 
 
29,699
 
 
(20,589
)
 
9,110
 
Trade names
 
 
663
 
 
(32
)
 
631
 
Assets not subject to amortization:
 
 
 
 
 
 
 
 
 
 
Trade names
 
 
357,326
 
 
-
 
 
357,326
 
Balances at March 31, 2014
 
$
2,682,812
 
$
(684,888
)
$
1,997,924
 

Amortization expense of other intangible assets was $38,049 and $33,084 during the three months ended March 31, 2014 and 2013, respectively.

An evaluation of the carrying value of goodwill and indefinite-lived intangibles is required to be performed on an annual basis and on an interim basis if an event occurs or circumstances change that would more likely than not reduce the fair value of a reporting unit below its carrying value. There have been no events or changes in circumstances which indicate an interim impairment review is required in 2014. The Company expects to perform the annual analysis during the fourth quarter.


7.
Debt

Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the three month period ended March 31, 2014, 911 notes were converted by note holders for $1.6 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.1 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.

At March 31, 2014, the conversion price on the remaining outstanding notes was $479.35 per note.  If converted at March 31, 2014, the value would have exceeded the $8 million principal amount of the outstanding notes by $20 million and could have resulted in the issuance of 149,613 shares of Roper's common stock.


8.
Fair Value of Financial Instruments

Roper's debt at March 31, 2014 included $2.2 billion of fixed-rate senior notes with the following fair values (in millions):

$400 million senior notes due 2017
$ 400
$800 million senior notes due 2018
790
$500 million senior notes due 2019
580
$500 million senior notes due 2022
475

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt included $8 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.


9.
Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. It is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized. A summary of the warranty accrual activity for the three months ended March 31, 2014 is presented below (in thousands):


Balance at December 31, 2013
 
$
14,336
 
Additions charged to costs and expenses
 
 
3,305
 
Deductions
 
 
(4,072
)
Other
 
 
(41
)
Balance at March 31, 2014
 
$
13,528
 



10.
Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

 
 
Three months ended March 31,
 
 
 
 
 
2014
 
2013
 
Change
 
Net sales:
 
 
 
 
 
 
 
 
 
Industrial Technology
 
$
197,001
 
$
182,239
 
8.1
%
Energy Systems & Controls
 
 
155,171
 
 
145,642
 
6.5
 
Medical & Scientific Imaging
 
 
256,199
 
 
200,444
 
27.8
 
RF Technology
 
 
225,681
 
 
208,810
 
8.1
 
Total
 
$
834,052
 
$
737,135
 
13.1
%
Gross profit:
 
 
 
 
 
 
 
 
 
Industrial Technology
 
$
98,470
 
$
93,311
 
5.5
%
Energy Systems & Controls
 
 
85,965
 
 
80,906
 
6.3
 
Medical & Scientific Imaging
 
 
184,850
 
 
134,869
 
37.1
 
RF Technology
 
 
119,651
 
 
112,490
 
6.4
 
Total
 
$
488,936
 
$
421,576
 
16.0
%
Operating profit*:
 
 
 
 
 
 
 
 
 
Industrial Technology
 
$
56,056
 
$
52,945
 
5.9
%
Energy Systems & Controls
 
 
37,025
 
 
35,722
 
3.6
 
Medical & Scientific Imaging
 
 
89,771
 
 
59,928
 
49.8
 
RF Technology
 
 
62,560
 
 
56,630
 
10.5
 
Total
 
$
245,412
 
$
205,225
 
19.6
%
Long-lived assets:
 
 
 
 
 
 
 
 
 
Industrial Technology
 
$
49,022
 
$
45,626
 
7.4
%
Energy Systems & Controls
 
 
18,503
 
 
19,032
 
(2.8
)
Medical & Scientific Imaging
 
 
39,948
 
 
40,198
 
(0.6
)
RF Technology
 
 
29,714
 
 
29,158
 
1.9
 
Total
 
$
137,187
 
$
134,014
 
2.4
%

* Segment operating profit is before unallocated corporate general and administrative expenses of $22,012 and $20,048 for the three months ended March 31, 2014 and 2013, respectively.



ITEM 2.                          MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report for the year ended December 31, 2013 as filed on February 21, 2014 with the SEC and the notes to our Condensed Consolidated Financial Statements included elsewhere in this report.


Information About Forward-Looking Statements

This report includes "forward-looking statements" within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the U.S. Securities and Exchange Commission ("SEC") or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are "forward-looking statements."  Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement.

Examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our internal operating plans, our expectations regarding our ability to generate operating cash flows and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, timing and success of product upgrades and new product introductions, raw materials costs, expected pricing levels, the timing and cost of expected capital expenditures, expected outcomes of pending litigation, competitive conditions, general economic conditions and expected synergies relating to acquisitions, joint ventures and alliances. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, but are not limited to:

·
general economic conditions;
·
difficulty making acquisitions and successfully integrating acquired businesses;
·
any unforeseen liabilities associated with future acquisitions;
·
limitations on our business imposed by our indebtedness;
·
unfavorable changes in foreign exchange rates;
·
difficulties associated with exports;
·
risks and costs associated with our international sales and operations;
·
increased directors' and officers' liability and other insurance costs;
·
risk of rising interest rates;
·
product liability and insurance risks;
·
increased warranty exposure;
·
future competition;
·
the cyclical nature of some of our markets;
·
reduction of business with large customers;
·
risks associated with government contracts;
·
changes in the supply of, or price for, raw materials, parts and components;
·
environmental compliance costs and liabilities;
·
risks and costs associated with asbestos-related litigation;
·
potential write-offs of our substantial goodwill and other intangible assets;
·
our ability to successfully develop new products;
·
failure to protect our intellectual property;
·
the effect of, or change in, government regulations (including tax);
·
economic disruption caused by terrorist attacks, health crises or other unforeseen events; and
·
the factors discussed in other reports filed with the SEC.

We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.


Overview

Roper Industries, Inc. ("Roper," "we" or "us") is a diversified growth company that designs, manufactures and distributes radio frequency ("RF") products, services and application software, industrial technology products, energy systems and controls and medical and scientific imaging products and software. We market these products and services to a broad range of markets, including RF applications, medical, water, energy, research, education, software-as-a-service ("SaaS")-based information networks, security and other niche markets.

We pursue consistent and sustainable growth in earnings by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other carefully selected businesses that offer high value-added services, engineered products and solutions and are capable of achieving growth and maintaining high margins. Our acquisitions have represented both financial bolt-ons and new strategic platforms. We strive for high cash and earnings returns from our investments.


Critical Accounting Policies

There were no material changes during the quarter ended March 31, 2014 to the items that we disclosed as our critical accounting policies and estimates in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2013 Annual Report on Form 10-K filed on February 21, 2014.


Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the Notes to Condensed Consolidated Financial Statements.
 
Results of Operations

General

The following table sets forth selected information for the periods indicated. Dollar amounts are in thousands and percentages are the particular line item shown as a percentage of net sales. Percentages may not foot due to rounding.

 
 
Three months ended  March 31,
 
 
 
2014
 
2013
 
Net sales:
 
 
 
 
 
 
 
Industrial Technology
 
$
197,001
 
$
182,239
 
Energy Systems & Controls
 
 
155,171
 
 
145,642
 
Medical & Scientific Imaging
 
 
256,199
 
 
200,444
 
RF Technology
 
 
225,681
 
 
208,810
 
Total
 
$
834,052
 
$
737,135
 
Gross profit:
 
 
 
 
 
 
 
Industrial Technology
 
 
50.0
%
 
51.2
%
Energy Systems & Controls
 
 
55.4
 
 
55.6
%
Medical & Scientific Imaging
 
 
72.2
 
 
67.3
%
RF Technology
 
 
53.0
 
 
53.9
%
Total
 
 
58.6
 
 
57.2
%
Selling, general & administrative expenses:
 
 
 
 
 
 
 
Industrial Technology
 
 
21.5
%
 
22.2
%
Energy Systems & Controls
 
 
31.5
 
 
31.0
 
Medical & Scientific Imaging
 
 
37.1
 
 
37.4
 
RF Technology
 
 
25.3
 
 
26.8
 
Total
 
 
29.2
 
 
29.4
 
Segment operating profit:
 
 
 
 
 
 
 
Industrial Technology
 
 
28.5
%
 
29.1
%
Energy Systems & Controls
 
 
23.9
 
 
24.5
 
Medical & Scientific Imaging
 
 
35.0
 
 
29.9
 
RF Technology
 
 
27.7
 
 
27.1
 
Total
 
 
29.4
 
 
27.8
 
Corporate administrative expenses
 
 
(2.6
)
 
(2.7
)
 
 
 
26.8
 
 
25.1
 
Interest expense
 
 
(2.4
)
 
(2.8
)
Other income/(expense)
 
 
0.2
 
 
(0.3
)
Earnings before income taxes
 
 
24.6
 
 
22.0
 
Income taxes
 
 
(6.9
)
 
(5.0
)
Net earnings
 
 
17.7
%
 
16.9
%




Three months ended March 31, 2014 compared to three months ended March 31, 2013

Net sales for the quarter ended March 31, 2014 increased by 13% as compared to the first quarter of 2013. The increase was the result of organic growth of 8% and sales related to 2013 acquisitions of 5%.

In our Industrial Technology segment, net sales increased by 8% to $197 million in the first quarter of 2014 as compared to $182 million in the first quarter of 2013, due primarily to increased sales in our water meter and materials testing businesses.  Gross margin decreased to 50.0% for the first quarter of 2014 as compared to 51.2% for the first quarter of 2013 due to product mix. Selling, general and administrative ("SG&A") expenses as a percentage of net sales decreased to 21.5% in the current year quarter from 22.2% in the prior year quarter due to operating leverage on higher sales volume. The resulting operating margin was 28.5% in the first quarter of 2014 as compared to 29.1% in the first quarter of 2013.

Net sales in our Energy Systems & Controls segment increased by 7% to $155 million during the first quarter of 2014 compared to $146 million in the first quarter of 2013.  Organic sales increased by 5% and acquisitions added 2%.  The increase in organic sales was due to sales of new instruments for refinery applications.  Gross margin was relatively unchanged at 55.4% in the first quarter of 2014, as compared to 55.6% in the first quarter of 2013. SG&A expenses as a percentage of net sales were 31.5% compared to 31.0% in the prior year quarter due to integration expenses related to our latest acquisition. As a result, operating margin was 23.9% in the first quarter of 2014 as compared to 24.5% in the first quarter of 2013.

Our Medical & Scientific Imaging segment net sales increased by 28% to $256 million in the first quarter of 2014 as compared to $200 million in the first quarter of 2013.  Organic sales increased by 9% and acquisitions completed in 2013 added 19%. The increase in organic sales was due to increased sales in our medical businesses. Gross margin increased to 72.2% in the first quarter of 2014 from 67.3% in the first quarter of 2013 due primarily to additional sales from medical products and software which have a higher gross margin.  SG&A expenses as a percentage of net sales were 37.1% in the first quarter of 2014 as compared to 37.4% in the first quarter of 2013 due to leverage on higher sales volume, offset in part by a higher SG&A expense structure related to the 2013 acquisition.  As a result, operating margin was 35.0% in the first quarter of 2014 as compared to 29.9% in the first quarter of 2013.

In our RF Technology segment, net sales were $226 million in the first quarter of 2014 as compared to $209 million in the first quarter of 2013, an increase of 8%.  The increase was due primarily to growth in our toll and traffic businesses.  Gross margin decreased to 53.0% as compared to 53.9% in the prior year quarter due to product mix in our toll and traffic businesses.  SG&A expenses as a percentage of net sales in the first quarter of 2014 decreased to 25.3% as compared to 26.8% in the prior year due to operating leverage on higher sales volume. The resulting operating margin was 27.7% in 2014 as compared to 27.1% in 2013.

Corporate expenses were $22.0 million, or 2.6% of sales, in the first quarter of 2014 as compared to $20.0 million, or 2.7% of sales, in the first quarter of 2013.  The increase was due to higher compensation costs, including increased stock-based compensation costs (see Note 4 of the Notes to Condensed Consolidated Financial Statements for details of stock-based compensation costs).

Interest expense was $20 million for the first quarter of 2014 as compared to $21 million for the first quarter of 2013.  The decrease was due to lower average interest rates on higher average outstanding debt balances.

Other income was $1.4 million in the first quarter of 2014, as compared to other expense of $2.5 million in the first quarter of 2013 due to foreign exchange gains and losses at our non-U.S. based subsidiaries.

Income taxes were 28.2% of pretax earnings in the first quarter of 2014, higher than the 22.8% rate experienced in the first quarter of 2013.  The current year rate was impacted by a $6 million reduction in the liability for unrecognized tax benefits due to the lapse of applicable statute of limitations. The prior year quarter was lower due to $6 million in discrete tax benefits related to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), as well as a $6 million benefit from the correction of an out of period adjustment of tax balances which were immaterial to any covered period.  We expect the effective tax rate for 2014 to be approximately 31%.

At March 31, 2014, the functional currencies of our European subsidiaries were stronger and the Canadian dollar was weaker against the U.S. dollar compared to currency exchange rates at December 31, 2013. The currency changes resulted in a pretax decrease of $14 million in the foreign exchange component of comprehensive earnings for the current year quarter, $8 million of which is related to goodwill and does not directly affect our expected future cash flows. During the quarter ended March 31, 2014, the functional currencies of our European subsidiaries were stronger and the Canadian dollar was weaker against the U.S. dollar as compared to the quarter ended March 31, 2013.  The difference in operating profit related to foreign exchange, translated into U.S. dollars, was less than 1% for these companies in the first quarter of 2014 compared to the first quarter of 2013.

Net orders were $846 million in the first quarter of 2014, 7% higher than the first quarter 2013 net order intake of $794 million.  Our order backlog at March 31, 2014 was 7% higher as compared to March 31, 2013. Acquisitions completed in 2013 contributed 5% to the current quarter orders.
 
 
 
 
Net orders booked for the
three months ended
March 31,
 
Order backlog as of March 31,
 
 
 
  2014
 
2013
 
2014
 
2013
 
 
 
(in thousands)
 
Industrial Technology
 
$
204,881
 
$
179,807
 
$
128,113
 
$
126,993
 
Energy Systems & Controls
 
 
150,915
 
 
157,537
 
 
127,445
 
 
120,921
 
Medical & Scientific Imaging
 
 
256,340
 
 
216,121
 
 
290,402
 
 
247,959
 
RF Technology
 
 
234,345
 
 
240,118
 
 
517,736
 
 
501,065
 
Total
 
$
846,481
 
$
793,583
 
$
1,063,696
 
$
996,938
 

 

 
Financial Condition, Liquidity and Capital Resources

Selected cash flows for the three months ended March 31, 2014 and 2013 were as follows (in millions):

 
 
2014
   
2013
 
Cash provided by/(used in):
 
   
 
Operating activities
 
$
212.6
   
$
171.3
 
Investing activities
   
(12.5
)
   
(13.2
)
Financing activities
   
(154.6
)
   
(88.8
)

Operating activities - Net cash provided by operating activities increased by 24% to $213 million in the first quarter of 2014 as compared to $171 million in the first quarter of 2013 due to increased earnings net of intangible amortization related to acquisitions, improved receivables collection and lower incentive compensation payments.

Investing activities - Cash used in investing activities during the quarters ended March 31, 2014 and 2013 was primarily for capital expenditures.

Financing activities - Cash used in financing activities was primarily for debt principal repayments and dividends in the quarter ended March 31, 2014 and primarily for debt principal repayments in the quarter ended March 31, 2013.  Cash provided by financing activities in the first quarters of 2014 and 2013 was primarily from stock option proceeds. Net debt payments were $150 million in the three months ended March 31, 2014 as compared to $100 million in the three months ended March 31, 2013.

Total debt at March 31, 2014 consisted of the following (amounts in thousands):

$400 million senior notes due 2017
$
400,000
 
$800 million senior notes due 2018
 
800,000
 
$500 million senior notes due 2019
 
500,000
 
$500 million senior notes due 2022
 
500,000
 
Senior Subordinated Convertible Notes
 
7,910
 
Revolving Facility
 
100,000
 
Other
 
7,156
 
Total debt
 
2,315,066
 
Less current portion
 
10,923
 
Long-term debt
$
2,304,143
 

The interest rate on borrowings under our $1.5 billion credit facility is calculated based upon various recognized indices plus a margin as defined in the credit agreement. At March 31, 2014, there were $100 million of outstanding borrowings under the facility.  At March 31, 2014, we had $7.2 million of other debt in the form of capital leases, several smaller facilities that allow for borrowings or the issuance of letters of credit in various foreign locations to support our non-U.S. businesses and $41 million of outstanding letters of credit.

Cash and short-term investments at our foreign subsidiaries at March 31, 2014 totaled $386 million.  Repatriation of these funds under current regulatory and tax law for use in domestic operations would expose us to additional taxes.  We consider this cash to be permanently reinvested.  We expect existing cash and cash equivalents, cash generated by our U.S. operations, our unsecured credit facility, as well as our expected ability to access the capital markets, will be sufficient to fund operating requirements in the U.S. for the foreseeable future.

We were in compliance with all debt covenants related to our credit facilities throughout the quarter ended March 31, 2014.

Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was $272 million at March 31, 2014 compared to $282 million at December 31, 2013, reflecting decreases in working capital due primarily to the timing of income tax payments. Total debt was $2.32 billion at March 31, 2014 as compared to $2.46 billion at December 31, 2013, due to the use of operating cash flows to reduce outstanding debt.   Our leverage is shown in the following table:
 
 
 
March 31,
2014
 
 
 
December 31,
2013
 
Total Debt
 
$
2,315,066
 
 
 
$
2,464,852
 
Cash
 
 
(502,885
)
 
 
 
(459,720
)
Net Debt
 
 
1,812,181
 
 
 
 
2,005,132
 
Stockholders' Equity
 
 
4,357,245
 
 
 
 
4,213,050
 
Total Net Capital
 
$
6,169,426
 
 
 
$
6,218,182
 
 
 
 
 
 
 
 
 
 
 
Net Debt / Total Net Capital
 
 
29.4
%
 
 
 
32.3
%

At March 31, 2014, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Capital expenditures of $10 million and $11 million were incurred during the first quarters of 2014 and 2013, respectively. We expect capital expenditures for the balance of the year to be comparable to prior years as a percentage of sales.

There have been no significant changes to our contractual obligations from those disclosed in our 2013 Annual Report on Form 10-K filed on February 21, 2014.


Outlook

Current geopolitical uncertainties could adversely affect our business prospects. A significant terrorist attack or other global conflict could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these factor's effects on current economic conditions. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also would similarly disrupt the economy.

We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, the proceeds from the issuance of new debt or equity securities or some combination of these methods.

We anticipate that our recently acquired companies as well as our other companies will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of currently outstanding debt. However, the rate at which we can reduce our debt during 2014 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions and the financial performance of our existing companies; and none of these factors can be predicted with certainty.



ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See "Item 7A - Quantitative and Qualitative Disclosures about Market Risk," in our 2013 Annual Report on Form 10-K filed on February 21, 2014. There were no material changes during the quarter ended March 31, 2014.



ITEM 4.                            CONTROLS AND PROCEDURES
As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report ("Evaluation Date"). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.
Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
There were no changes to our internal controls during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.




Part II.                                        OTHER INFORMATION

Item 1.                                        Legal Proceedings

Information pertaining to legal proceedings can be found in Note 9 of the Notes to Condensed Consolidated Financial Statements included elsewhere in this report, and is incorporated by reference herein.



Item 1A.                          Risk Factors

For information regarding factors that could affect our results of operations, financial condition and liquidity, see the risk factors discussion in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2013 as filed on February 21, 2014 with the SEC. See also, "Information about Forward-Looking Statements" included in Part I, Item 2 of this Quarterly Report on Form 10-Q.



Item 6.                                        Exhibits

31.1
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
 
 
31.2
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
 
 
32.1
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
 
 
101.INS
XBRL Instance Document, furnished herewith.
 
 
101.SCH
XBRL Taxonomy Extension Schema Document, furnished herewith.
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.
 
 








Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Roper Industries, Inc.


/s/ Brian D. Jellison
 
Chairman of the Board, President,
May 2, 2014
Brian D. Jellison
 
and Chief Executive Officer
 
 
 
(Principal Executive Officer)
 


/s/ John Humphrey
 
Chief Financial Officer and
May 2, 2014
John Humphrey
 
Executive Vice President
 
 
 
(Principal Financial Officer)
 


/s/ Paul J. Soni
 
Vice President and Controller
May 2, 2014
Paul J. Soni
 
(Principal Accounting Officer)
 




EXHIBIT INDEX
TO REPORT ON FORM 10-Q


Number                                                                            Exhibit

31.1
Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
 
 
31.2
Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
 
 
32.1
Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
 
 
101.INS
XBRL Instance Document, furnished herewith.
 
 
101.SCH
XBRL Taxonomy Extension Schema Document, furnished herewith.
 
 
101.CAL
XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
 
 
101.DEF
XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
 
 
101.LAB
XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
 
 
101.PRE
XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.